Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001793412-26-000008

CHIEF FINANCIAL OFFICER sold 102,817 shares at an average $4.72 ($485,042)

From the SEC's structured data for this filing

Trades in this filing

Alam Kamran · CHIEF FINANCIAL OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-23 Sale : show line 1 in the form −78,968 $4.75 $375,098 1,467,635 D
2026-01-26 Sale : show line 2 in the form −23,849 $4.61 $109,944 1,443,786 D
Open-market sales · 102,817 sh · avg $4.72 · $485,042
Loading xslF345X05/form4-01272026_040101.xml…